← Search

Data · dataset · 2026

Scorpion-Inspired 1,3,4-Oxadiazole-Based GSK-3β-Targeting Agents: Design, Synthesis, and Biological Evaluation

Listed in ZivaHub

<p>Glycogen synthase kinase-3β (GSK-3β) is a promising therapeutic target for anticancer drug development because it is involved in cell proliferation, apoptosis, and tumor progression.

Description

However, developing structurally distinct GSK-3β-directed anticancer scaffolds with favorable cancer-cell selectivity remains challenging. In this study, 10 scorpion-inspired 2-(phenacylthio)-1,3,4-oxadiazole derivatives (<b>ODS1-10</b>) were synthesized in 65–97% yields and evaluated for their anticancer potential.

Among the synthesized compounds, <b>ODS-7</b> showed the highest activity against MDA-MB-231 cells (IC<sub>50</sub> = 32.7 μM), whereas <b>ODS-5</b> was the most active derivative against SH-SY5Y cells (IC<sub>50</sub> = 21.2 μM). Structure–activity relationship analysis indicated that the electronic properties and substitution pattern of the aryl moieties substantially influenced antiproliferative activity. <b>ODS-5</b> and <b>ODS-7</b> showed preferential activity toward cancer cells, with <b>ODS-5</b> exhibiting a selectivity index of 2.80 against non-cancerous HaCaT keratinocytes.

Read the rest (2 more)

Both compounds significantly reduced SH-SY5Y clonogenic capacity and disrupted three-dimensional spheroid integrity. Immunofluorescence analysis revealed reduced GSK-3β-associated fluorescence intensity in treated SH-SY5Y cells, while RT-qPCR demonstrated upregulation of BAX and CASP3 and downregulation of BCL2, supporting the involvement of apoptosis in the observed cytotoxic response. Molecular docking also showed favorable predicted binding energies for <b>ODS-5</b> (−8.67 kcal/mol) and <b>ODS-7</b> (−8.44 kcal/mol) within the GSK-3β binding site, comparable to the co-crystallized ligand 3HT (−8.37 kcal/mol).

Overall, <b>ODS-5</b> and <b>ODS-7</b> represent promising preliminary lead structures within the 2-(phenacylthio)-1,3,4-oxadiazole series, providing a rational SAR basis for further medicinal chemistry optimization and direct evaluation of GSK-3β target engagement.</p> <p>Multi-panel diagram depicting a scorpion-inspired design, synthesized derivatives, target engagement with GSK-3ß, and mechanistic marker results.</p>

Links

Where it is published

Catalogue records · 1

Topics

Provenance · 1 source records, 12 field assertions
SourceKeyLast seenRaw
ZivaHuboai:figshare.com:article/3402167313 d agoJSON v1
FieldAssertionExtractorEvidence
access_levelsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[disease].local:disease:cancermapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Cancer']
concepts[field].anzsrc:group:3101mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Cell Biology']
concepts[field].anzsrc:group:3204mapping · zivahub uct ac zavocabulary-mapper@1.0.0keywords['Immunology']
concepts[field].local:field:chemistrymapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:earth-environmentalmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:life-sciencesmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
concepts[field].local:field:medicine-healthmapping · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
descriptionsource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/description
licensesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/rights
publication_datesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0
titlesource · zivahub uct ac zaconnector:zivahub_uct_ac_za@1.0.0/metadata/dc/title